Jubilant Radiopharma is an industry leading pharmaceutical company specializing in nuclear medicine focused on developing, manufacturing, commercializing and distributing high quality and sustainable diagnostic and therapeutic agents for the sole purpose of Improving Lives Through Nuclear Medicine on a global scale.
Location: United States, Florida, Orlando
Member count: 501-1000
Founded date: 2006
Investors 1
| Date | Name | Website |
| - | Parthenon ... | parthenonc... |
Mentions in press and media 6
| Date | Title | Description | Source |
| 27.06.2023 | ASP Isotopes Inc. Secures $9 Million Supply Contract with US... | Approximately $900,000 to be Recorded in 3Q23, with Deliveries Anticipated to Begin in Q1 of 2024. ... | einpresswi... |
| 27.06.2023 | ASP Isotopes Inc. Secures $9 Million Supply Contract with US... | - | globenewsw... |
| 22.02.2011 | 2010 Year-End Review | We had a strong finish to 2010 with high activity levels in regards to both the portfolio and new pl... | parthenonc... |
| 01.06.2010 | Triad Isotopes Closes Acquisition of Covidien’s U.S. Network... | ORLANDO, FL—Triad Isotopes, Inc., a portfolio company of Parthenon Capital Partners, announced today... | parthenonc... |
| 17.12.2009 | Covidien to ditch U.S. radiopharmacies | Covidien (NYSE:COV) agreed to sell its 37 radiopharmacies in the U.S. to Triad Isotopes Inc. of Orla... | massdevice... |
| 17.12.2009 | Triad Isotopes Announces Agreement to Acquire Network of Cov... | Orlando, Florida – Triad Isotopes, Inc., a portfolio company of Parthenon Capital Partners, today an... | parthenonc... |